CD10 is useful in demonstrating endometrial stroma at ectopic sites and in confirming a diagnosis of endometriosis
- 1 May 2002
- journal article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 55 (5) , 391-392
- https://doi.org/10.1136/jcp.55.5.391
Abstract
Aims: Recent studies have shown that CD10 is a useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms. The aim of this study was to investigate whether CD10 immunoreactivity is present in ectopic endometrial stroma and whether staining is of value in confirming a diagnosis of endometriosis. Methods/Results: Twenty five cases of endometriosis were stained with a commercially available antibody against CD10. Endometrial stromal cells were positive in 22 of 25 cases. There was little or no staining of other tissues. Conclusions: CD10 immunoreactivity is largely maintained in endometrial stromal cells located outside the uterus. Immunohistochemical staining with CD10 may be of value in confirming a diagnosis of endometriosis when there is morphological doubt.Keywords
This publication has 7 references indexed in Scilit:
- CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasmsHistopathology, 2001
- Utility of CD10 in Distinguishing between Endometrial Stromal Sarcoma and Uterine Smooth Muscle Tumors: An Immunohistochemical Comparison of 34 CasesLaboratory Investigation, 2001
- Paraffin-Section Detection of CD10 in 505 Nonhematopoietic NeoplasmsAmerican Journal of Clinical Pathology, 2000
- Molecular Analysis of Clonality in Ovarian Endometrial CystsGynecologic and Obstetric Investigation, 1999
- Monoclonal origin of endometriotic cystsInternational Journal of Gynecologic Cancer, 1995
- Stromal Endometriosis of the Uterine CervixThe American Journal of Surgical Pathology, 1990
- Antisera to acute lymphoblastic leukemia cellsClinical Immunology and Immunopathology, 1975